Total Payments
$16,890
2024 Payments
$972.29
Companies
47
Transactions
917
Medicare Patients
4,979
Medicare Billing
$464,050
Payment Breakdown by Category
Food & Beverage$16,680 (98.8%)
Other$200.00 (1.2%)
Education$9.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,680 | 914 | 98.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.2% |
| Education | $9.48 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $3,305 | 175 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,595 | 171 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,283 | 63 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,260 | 56 | $0 (2024) |
| Amgen Inc. | $1,216 | 60 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $1,087 | 67 | $0 (2024) |
| PFIZER INC. | $893.01 | 64 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $613.03 | 42 | $0 (2019) |
| Amarin Pharma Inc. | $397.30 | 26 | $0 (2022) |
| Boston Scientific Corporation | $395.45 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $972.29 | 50 | Novartis Pharmaceuticals Corporation ($323.05) |
| 2023 | $2,339 | 118 | Novartis Pharmaceuticals Corporation ($482.69) |
| 2022 | $2,383 | 128 | Janssen Pharmaceuticals, Inc ($536.34) |
| 2021 | $1,835 | 93 | Janssen Pharmaceuticals, Inc ($474.12) |
| 2020 | $1,077 | 67 | Janssen Pharmaceuticals, Inc ($493.78) |
| 2019 | $2,429 | 135 | Janssen Pharmaceuticals, Inc ($411.43) |
| 2018 | $2,642 | 151 | Janssen Pharmaceuticals, Inc ($508.17) |
| 2017 | $3,213 | 175 | Janssen Pharmaceuticals, Inc ($563.79) |
All Payment Transactions
917 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.27 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: DIABETES | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: DIABETES | ||||||
| 05/02/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Coronary | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: DIABETES | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/25/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,245 | 1,852 | $282,130 | $92,270 |
| 2022 | 21 | 1,318 | 1,862 | $425,051 | $115,438 |
| 2021 | 19 | 1,235 | 1,892 | $451,174 | $141,382 |
| 2020 | 17 | 1,181 | 1,714 | $360,433 | $114,961 |
Total Patients
4,979
Total Services
7,320
Medicare Billing
$464,050
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 202 | $43,430 | $19,713 | 45.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 249 | $48,500 | $16,491 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 182 | $50,050 | $15,194 | 30.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 89 | 95 | $39,425 | $13,429 | 34.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 36 | 39 | $19,695 | $5,831 | 29.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 72 | $10,800 | $4,671 | 43.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 82 | 84 | $12,180 | $4,488 | 36.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 226 | 417 | $22,935 | $4,272 | 18.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 296 | 374 | $14,960 | $2,317 | 15.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 12 | 12 | $5,280 | $1,746 | 33.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 16 | $6,160 | $1,705 | 27.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $3,120 | $973.47 | 31.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 12 | 12 | $2,180 | $622.13 | 28.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 24 | 29 | $1,595 | $584.06 | 36.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 23 | 28 | $980.00 | $162.68 | 16.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 23 | 28 | $840.00 | $69.16 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 305 | $81,866 | $26,405 | 32.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 67 | 188 | $41,440 | $15,113 | 36.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 86 | $32,434 | $11,399 | 35.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 72 | 72 | $55,575 | $10,305 | 18.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 63 | $26,407 | $9,762 | 37.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 26 | 26 | $34,800 | $9,696 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 112 | $18,654 | $6,560 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 76 | $14,680 | $4,517 | 30.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 74 | 74 | $12,680 | $3,926 | 31.0% |
About Dr. Peter Correnti, DO
Dr. Peter Correnti, DO is a Cardiovascular Disease healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487659421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Correnti, DO has received a total of $16,890 in payments from pharmaceutical and medical device companies, with $972.29 received in 2024. These payments were reported across 917 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($16,680).
As a Medicare-enrolled provider, Correnti has provided services to 4,979 Medicare beneficiaries, totaling 7,320 services with total Medicare billing of $464,050. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Clermont, FL
- Active Since 06/16/2005
- Last Updated 07/02/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1487659421
Products in Payments
- XARELTO (Drug) $3,350
- ENTRESTO (Drug) $2,264
- ELIQUIS (Drug) $1,340
- LifeVest (Device) $1,283
- JARDIANCE (Drug) $875.39
- Corlanor (Drug) $790.07
- Repatha (Biological) $425.91
- PRALUENT ALIROCUMAB INJECTION (Biological) $407.14
- Vascepa (Drug) $397.30
- PRADAXA (Drug) $384.76
- LEQVIO (Drug) $331.30
- Veltassa (Drug) $306.72
- FFRct (Device) $292.85
- CAMZYOS (Drug) $233.33
- BRILINTA (Drug) $225.44
- PRALUENT (Drug) $215.73
- NORTHERA (Drug) $210.72
- CHANTIX (Drug) $207.78
- PRALUENT (Biological) $205.89
- VYNDAQEL (Drug) $198.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Clermont
Dr. Adheesh Agnihotri, M.d, M.D
Cardiovascular Disease — Payments: $21,110
Cardiovascular Disease $21,110
Louis Kantounis, Md, MD
Cardiovascular Disease — Payments: $5,396
Cardiovascular Disease $5,396
Sundeep Mediratta, Md, MD
Cardiovascular Disease — Payments: $5,000
Cardiovascular Disease $5,000
Abbas Ali, M.d, M.D
Cardiovascular Disease — Payments: $2,912
Cardiovascular Disease $2,912
Dr. Shobashalini Chokkalingam, Md, MD
Cardiovascular Disease — Payments: $2,156
Cardiovascular Disease $2,156
Sandeep Anreddy, Md, MD
Cardiovascular Disease — Payments: $1,350
Cardiovascular Disease $1,350